CN102579787A - 一种治疗慢性胃炎的中药组合物 - Google Patents
一种治疗慢性胃炎的中药组合物 Download PDFInfo
- Publication number
- CN102579787A CN102579787A CN201210071188XA CN201210071188A CN102579787A CN 102579787 A CN102579787 A CN 102579787A CN 201210071188X A CN201210071188X A CN 201210071188XA CN 201210071188 A CN201210071188 A CN 201210071188A CN 102579787 A CN102579787 A CN 102579787A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chronic gastritis
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 21
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 244000207032 American speedwell Species 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 240000001080 Grifola frondosa Species 0.000 claims abstract description 12
- 235000007710 Grifola frondosa Nutrition 0.000 claims abstract description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 230000036407 pain Effects 0.000 description 11
- 235000013305 food Nutrition 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 210000001156 gastric mucosa Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000002575 gastroscopy Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 201000009442 piebaldism Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068786 Overlap syndrome Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010042458 Suicidal ideation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗慢性胃炎的中药组合物。该中药组合物是由茯苓,仙桃草,瞿麦,灰树花,百合,厚朴,川芎,元胡,白芍,甘草,木香制成。临床可用于治疗慢性胃炎,安全有效,成本低廉。
Description
技术领域
本发明涉及一种治疗慢性胃炎的中药组合物,属于中药领域。
背景技术
慢性胃炎是一组以持续性或反复性发作上腹部疼痛、食后饱胀、腹部胀气、嗳气、早饱、厌食、恶心等上腹部不适为主要症状的临床症候群,属功能性胃肠病范畴。各国报道的患病率在20~49%之间,在我国以消化不良症状就诊者约占消化门诊的20~40%,慢性胃炎发病率在我国呈进一步上升趋势,一直是消化病领域的研究热点。对于慢性胃炎,目前西药治疗主要是促胃肠动力、保护胃黏膜中药及抑酸中药的运用,对伴有心理异常者用抗抑郁焦虑中药,疗效远不能令人满意,并且容易反复,缺乏针对多病因的个体化诊疗方案。
发明内容
本发明所要解决的技术问题是克服现有慢性胃炎的中药制剂病因和发病机制不明确、以及仅对症治疗的缺陷,提供一种采用中药、通过调节肝脾治疗的慢性胃炎的中药组合物及其制备方法,该组合物安全有效、成本低廉、便于掌握。为解决上述技术问题,本发明采用茯苓,仙桃草,瞿麦,灰树花,百合,厚朴,川芎,元胡,白芍,甘草,木香制成中药组合物,在治疗慢性胃炎方面取得了疗效显著的有益效果。
本发明中药的药理作用如下:
茯苓:甘、淡、平。归心、脾、肺、肾经。渗湿利水,健脾和胃,宁心安神。用于小便不利,水肿胀满,痰饮咳逆,呕吐,脾虚食少,泄泻,心悸不安,失眠健忘,遗精白浊等。仙桃草:甘、微辛,性平。化瘀止血,清热消肿,止痛。用于跌打损伤,咽喉肿痛,痈疽疮痈,吐血,咳血,肚胃气痛,痛经等。灰树花:甘、平。益气健脾、补虚扶正。用于脾虚气弱,体倦乏力,神疲懒言;饮食减少、食后腹胀;肿瘤患者放疗或化疗后有上述症状者。百合:甘、微苦,微寒,归心,肺经。养阴润燥,清心安神。主治阴虚久咳或情志不遂所致的虚烦惊悸,失眠多梦。厚朴:苦、辛、温。归脾、胃、大肠经。行气消积,燥湿除满,降逆平喘。用于食积气滞,腹胀便秘,湿阻中焦,脘痞吐泻等。川芎:辛、温,归肝、胆、心经。活血行气,祛风止痛。用于血瘀气滞、风湿痹痛。元胡:辛、苦、温。归肝、胃、心、肺、脾经。活血、散瘀、理气、止痛。用于心腹腰膝诸痛、月经不调、跌打损伤等。白芍:苦、酸,微寒,归肝,脾经。养血和营,缓急止痛,敛阴平肝。主治血虚寒热,脘腹疼痛,头痛眩晕。甘草:甘、平,归心、肺、脾、胃经。益气补中,清热解毒,祛痰止咳,缓急止痛,调和药性。用于心气不足的心动悸、脉结代,热毒疮疡,咽喉肿痛。木香:辛、苦、温。归脾、胃、肝、肺经。行气止痛,调中导滞。主治胸胁胀满,脘腹胀痛,呕吐泄泻等。
上述治疗慢性胃炎的中药组合物,其特征在于该中药组合物是由茯苓10-30份,仙桃草10-30份,瞿麦10-30份,灰树花10-20份,百合10-20份,厚朴10-20份,川芎10-20份,元胡10-20份,白芍5-15份,甘草5-15份,木香5-15份制成。
上述的治疗慢性胃炎的中药组合物,其特征在于该中药组合物是由茯苓20份,仙桃草20份,瞿麦20份,灰树花15份,百合15份,厚朴15份,川芎15份,元胡15份,白芍10份,甘草10份,木香10份制成。
本发明进一步采用的技术方案是,将茯苓,仙桃草,瞿麦,灰树花,百合,厚朴,川芎,元胡,白芍,甘草,木香混合,加水没过药材,然后慢火煎煮1小时,过滤后得到药汁,重复上述煎煮过程三次,将所得药汁混合,浓缩后即得汤剂。
本发明的另一发明目的是提供该中药组合物在制备治疗慢性胃炎药物中的应用。
本发明的中药组合物通过调节肝脾,对治疗慢性胃炎取得了良好的效果,能明显改善上腹胀满、上腹疼痛、腹胀、食欲不振、嗳气、烧心和反酸等症状,解决了西药病因和发病机制不明确、仅对症治疗的缺陷。
下述实验例通过观察本中药组合物治疗的疗效,进一步说明本发明药物的用途:
一、研究对象
1.病例来源
为青州市人民医院消化科收治的门诊及住院病人60例,均符合下述纳入标准,不符合排除标准。
2.纳入标准
(1)符合慢性胃炎辨证标准;(2)年龄在18~65岁之间,性别不限;(3)知情同意,志愿受试,知情同意过程符合GCP的规定。
3.排除标准
(1)辨证不明确或不属于慢性胃炎者;(2)合并消化性溃疡、糜烂性胃炎、腹部手术史、胃黏膜有重度异型增生或病理诊断疑有恶变者;(3)合并胃食管反流病、肠易激综合征的重叠综合征者;(4)有结缔组织疾病、糖尿病等内分泌代谢疾病者、更年期综合症者;具有严重的原发性心、肝、肺、肾、血液或影响其生存的严重疾病者;(5)妊娠、哺乳期妇女;法律规定的残疾患者(盲,聋,哑,智力障碍,精神障碍,肢体残疾);(6)怀疑或确有酒精、中药滥用病史;(7)过敏体质,如对两种或以上中药或食物过敏史者,或已知对本药成分过敏者;(8)处于重度焦虑抑郁状态,有自杀倾向的患者;(9)根据研究者的判断、具有降低入组可能性或使入组复杂化的其他病变,如工作环境经常变动等易造成失访的情况;(10)正在参加其他中药临床试验的患者。
4.诊断标准
参照SFDA2002年公布实施的《中药新药临床研究指导原则》中“中药新药治疗痞满的临床研究指导原则”和2006年中华中医药学会脾胃病分会编著的《中医消化病诊疗指南》制定。具体如下:
主症:①胃痛隐隐或痞满,绵绵不休;②喜暖喜按,空腹痛甚,得食则缓,劳累或受凉后发作或加重。次症:①泛吐清水;②神疲纳呆,四肢倦怠;③手足不温,大便溏薄;④舌淡苔白;⑤脉虚弱。证候确定:具备主症加次症2项即可诊断为慢性胃炎。
二、方法:
1.治疗方法:茯苓20g,仙桃草20g,瞿麦20g,灰树花15g,百合15g,厚朴15g,川芎15g,元胡15g,白芍10g,甘草10g,木香10g,上述药物按照常规方法加工成汤剂,每天1剂,每天2次,1个月为1个疗程。
2.饮食及调护:病人在进行药物治疗的同时,均采取以下调护措施。
2.1细嚼慢咽,减少食物对胃粘膜的刺激。
2.2饮食应有节律,忌暴饮暴食及食无定时。
2.3注意饮食卫生,杜绝外界微生物对胃粘膜的侵害。
2.4尽量做到进食较精细易消化、富有营养的食物。
2.5清淡少食肥、甘、厚、腻、辛辣等食物,少饮酒及浓茶。平日需多进食富含β-胡萝卜素、维生素C以及叶酸的食物,如猕猴桃、柑橘、草莓和动物肝脏、绿色蔬菜等。
2.6尽量避免用损害胃粘膜的药物,如阿斯匹林、消炎痛、红霉素、可的松等。
3.疗效性指标:
疗效标准依照《中医病症诊断疗效标准》和《中药新药临床研究指导原则》拟定①临床治愈:按临床症状和体征消失,胃镜检查胃粘膜病变恢复正常;②显效:临床症状和体征明显改善,病变粘膜基木恢复;③有效:临床症状和体征改善,病变胃粘膜范围缩小为原来的2/3;④无效:临床症状和体征无明显变化,病变胃粘膜无改变。
4.统计方法:总有效率比较采用x2检验。
三、结果:
1、临床疗效结果
60例中,治愈30例(50.00%),显效15例(25.00%),有效10例(16.70%),无效5例(8.30%),总有效率为91.70%。
2、治疗前后胃镜检查比较
60例中,治疗前胃粘膜充血60例,水肿30例,糜烂13例,花斑19例,出血11例;治疗后胃粘膜充血10例(83.33%),水肿5例(83.33%),糜烂5例(61.54%),花斑9例(52.63%),出血2例(81.82%),平均有效率为72.53%。
3、治疗前后临床症状比较,具体见表1
表1治疗前后临床症状比较(n)
注:与治疗前相比,*P<0.05
4.不良事件
所有入组病例在治疗和随访过程中均未出现不良反应或不良事件。
5.典型病例
5.1孙某,男,41岁,胃脘疼痛间作10年,胃脘疼痛、胀满,受凉饮食生冷后加重,嗳气,无泛酸烧心,无恶心呕吐,无口干口苦,乏力,纳差,进食少量即觉饱胀,大便2-3次/日,稀溏,小便调。舌淡苔白,脉细弱。餐前服用,早晚各一次,1个疗程后痊愈,随访半年,未再复发。
5.2吴某,女,56岁,胃脘痞满不适间作10余年,胃脘痞满,偶有胃脘隐痛,喜温喜按,嗳气频作,无泛酸烧心,偶有恶心无呕吐,口干口苦,手足不温,乏力,纳差,进食少量即觉饱胀,大便不成形,小便调。舌淡苔白,脉细弱。餐前服用,早晚各一次,1个疗程后痊愈,随访1年,未再复发。
具体实施例
实施例1:
按照茯苓20g,仙桃草20g,瞿麦20g,灰树花15g,百合15g,厚朴15g,川芎15g,元胡15g,白芍10g,甘草10g,木香10g称取各中药原材料,将称取的上述各中药混合,加水没过药材,然后慢火煎煮1小时,得到药汁。重复上述煎煮过程三次,将所得药汁混合浓缩后分成两份,每份200ml左右。
实施例2:
按照茯苓30g,仙桃草30g,瞿麦30g,灰树花20g,百合20g,厚朴20g,川芎20g,元胡20g,白芍15g,甘草15g,木香15g称取各中药原材料,将称取的上述各中药混合,加水没过药材,然后慢火煎煮1小时,得到药汁。重复上述煎煮过程三次,将所得药汁混合浓缩后分成两份,每份200ml左右。
实施例3:
按照茯苓10g,仙桃草10g,瞿麦10g,灰树花10g,百合10g,厚朴10g,川芎10g,元胡10g,白芍10g,甘草5g,木香5g称取各中药原材料,将称取的上述各中药混合,加水没过药材,然后慢火煎煮1小时,得到药汁。重复上述煎煮过程三次,将所得药汁混合浓缩后分成两份,每份200ml左右。
Claims (3)
1.一种治疗慢性胃炎的中药组合物,其特征在于包括下述原料药:茯苓10-30份,仙桃草10-30份,瞿麦10-30份,灰树花10-20份,百合10-20份,厚朴10-20份,川芎10-20份,元胡10-20份,白芍5-15份,甘草5-15份,木香5-15份。
2.根据权利要求1所述的中药组合物,其特征在于包括下述原料药:茯苓20份,仙桃草20份,瞿麦20份,灰树花15份,百合15份,厚朴15份,川芎15份,元胡15份,白芍10份,甘草10份,木香10份。
3.根据权利要求1或2所述中药组合物在制备治疗慢性胃炎药物中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210071188 CN102579787B (zh) | 2012-03-19 | 2012-03-19 | 一种治疗慢性胃炎的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210071188 CN102579787B (zh) | 2012-03-19 | 2012-03-19 | 一种治疗慢性胃炎的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102579787A true CN102579787A (zh) | 2012-07-18 |
| CN102579787B CN102579787B (zh) | 2013-06-19 |
Family
ID=46469389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210071188 Expired - Fee Related CN102579787B (zh) | 2012-03-19 | 2012-03-19 | 一种治疗慢性胃炎的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102579787B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296944A (zh) * | 2017-06-15 | 2017-10-27 | 合肥川迪医药技术有限公司 | 一种治疗慢性胃炎的中药及其制备方法 |
| CN107569645A (zh) * | 2017-10-21 | 2018-01-12 | 内蒙古民族大学附属医院 | 一种调理胃肠的蒙药及其制造方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1723943A (zh) * | 2005-07-06 | 2006-01-25 | 湖南敬和堂制药有限公司 | 一种治疗胃炎和消化性溃疡的中药组合物制备方法 |
| CN101607074A (zh) * | 2008-06-20 | 2009-12-23 | 天科仁祥技术(北京)有限责任公司 | 一种治疗慢性胃炎的药物组合及其制备方法 |
| CN101711844A (zh) * | 2009-12-24 | 2010-05-26 | 韩文刚 | 一种化滞通络的中药组合物 |
-
2012
- 2012-03-19 CN CN 201210071188 patent/CN102579787B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1723943A (zh) * | 2005-07-06 | 2006-01-25 | 湖南敬和堂制药有限公司 | 一种治疗胃炎和消化性溃疡的中药组合物制备方法 |
| CN101607074A (zh) * | 2008-06-20 | 2009-12-23 | 天科仁祥技术(北京)有限责任公司 | 一种治疗慢性胃炎的药物组合及其制备方法 |
| CN101711844A (zh) * | 2009-12-24 | 2010-05-26 | 韩文刚 | 一种化滞通络的中药组合物 |
Non-Patent Citations (3)
| Title |
|---|
| 田高娅: "中药治疗慢性胃炎100例", 《现代中西医结合杂志》, vol. 18, no. 26, 30 September 2009 (2009-09-30), pages 3205 * |
| 蒲文斌: "中药治疗慢性胃炎60例", 《实用中医药杂志》, vol. 26, no. 5, 31 May 2010 (2010-05-31), pages 312 * |
| 路向彬: "中药治疗慢性胃炎和消化性溃疡50例", 《中国民间疗法》, vol. 17, no. 4, 30 April 2009 (2009-04-30), pages 24 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296944A (zh) * | 2017-06-15 | 2017-10-27 | 合肥川迪医药技术有限公司 | 一种治疗慢性胃炎的中药及其制备方法 |
| CN107569645A (zh) * | 2017-10-21 | 2018-01-12 | 内蒙古民族大学附属医院 | 一种调理胃肠的蒙药及其制造方法 |
| CN107569645B (zh) * | 2017-10-21 | 2021-01-15 | 内蒙古民族大学附属医院 | 一种调理胃肠的蒙药及其制造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102579787B (zh) | 2013-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
| CN102178912A (zh) | 用于阳虚体质的人缓解胃脘冷痛症状的中药制剂及其制备方法和应用 | |
| CN103495040A (zh) | 治疗反流性食管炎的中药组合物及其颗粒剂制备方法 | |
| CN101249235A (zh) | 治疗食道癌的中药及其制备方法 | |
| CN101716318B (zh) | 一种用于辅助化疗方式治疗消化系统肿瘤的中药制剂 | |
| CN1772157A (zh) | 用于产妇催乳强身中草药剂 | |
| CN104940784A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN104352920A (zh) | 一种消食和胃的中药组合物 | |
| CN101085328A (zh) | 一种内服治疗慢性胃炎的中药组合物 | |
| CN102430105B (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN101773647B (zh) | 一种治疗十二指肠癌的中药组合物及其制备方法 | |
| CN102579787B (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN103330914A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN104258359A (zh) | 一种用于治疗妊娠反应的中药组合物及其制剂的制备方法 | |
| CN104548029A (zh) | 一种治疗胃脘痛的药物组合物 | |
| CN105944059A (zh) | 用于治疗胃病的中药组合物 | |
| CN103784924B (zh) | 一种止泻的中药组合物及其制备方法 | |
| CN104784650A (zh) | 一种用于临床护理胃溃疡的药物制剂 | |
| CN104707110A (zh) | 一种用于胰腺癌的中药制剂及制备方法 | |
| CN104399040A (zh) | 一种治疗胃胀的药物及其制备方法 | |
| CN1222364A (zh) | 辩证分型治疗癌症的内服、外敷、药膳系列药剂及制备方法 | |
| CN103520341A (zh) | 一种治疗食道癌的中药组方 | |
| CN103656459B (zh) | 一种治疗肺脾两虚证型咳嗽的中药 | |
| CN105748674A (zh) | 一种治疗小儿腹泻的外用中药散剂 | |
| CN104906391A (zh) | 一种治疗气阴两虚型十二指肠溃疡的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130619 |
